powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1184068363
Andrew Shakespeare
M.D.
Pulmonary Disease
Lubbock,
TX
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$7K
Payment records
112
By payment type
Travel and Lodging
$3K
Education
$3K
Food and Beverage
$2K
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (5)
CCN 321305
Hospital
CCN 380061
Hospital
CCN 450040
Hospital
CCN 450162
Hospital
CCN 453306
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
948
Beneficiaries
—
Total drug cost
$539K
Distinct drugs
19
Brand share
76.6%
Top prescribed drugs
Fluticasone/Umeclidin/Vilanter
285 claims
Budesonide/Glycopyr/Formoterol
132 claims
Azithromycin
121 claims
Albuterol Sulfate
107 claims
Prednisone
32 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
989
Unique beneficiaries
—
Total services
1,767
Distinct HCPCS
14
Medicare payment
$152K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 664 Pulmonary Disease providers in TX — above median (cohort median 1,111).
